Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL

Conditions:   Acute Lymphoblastic Leukemia, Adult;   Ph+ ALL;   Newly Diagnosed Intervention:   Drug: Ponatinib 15 MG Oral Tablet Sponsors:   Institute of Hematology and Blood Transfusion, Czech Republic;   CZECRIN - Czech Clinical Research Infrastructure Network Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials